Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102,168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endovascular Recanalization and Standard Medical Management for Symptomatic Non-acute Intracranial Artery Occlusion: Study Protocol for a Non-randomized, 24-Month, Multicenter Study.
Zhang H, Han J, Sun X, Miao Z, Guo X, Xu G, Sun Y, Wen C, Wang C, Wu Y, Xu Y, Jiang Y, Zhang S, Liu C, Li D, Liu Y, Xu C, Gao F. Zhang H, et al. Among authors: wang c. Front Neurol. 2021 Sep 28;12:729534. doi: 10.3389/fneur.2021.729534. eCollection 2021. Front Neurol. 2021. PMID: 34650509 Free PMC article.
Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
Tao C, Qureshi AI, Yin Y, Li J, Li R, Xu P, Sun J, Liao G, Yue X, Shi H, Liu Y, Ma Z, Zhang J, Xiao G, Xu B, Xu C, Su J, Zhou W, Huang S, Yang W, Chen H, Li W, Li Y, Liu D, Yu C, Yuan G, Wang C, Liang W, Chen C, Shi X, Wang J, Wu Y, Cai X, Shen C, Li K, Fang P, Wang M, Chen Z, Li T, Cheng G, Sun Y, Wang Y, Zhang H, Chen J, Xu X, Wang Y, Geng W, Ni C, Chen C, Liu Y, Min J, Zhang Y, Liang Y, Wen C, Baxter BW, Nogueira RG, Hu W; ATTENTION (Endovascular Treatment for Acute Basilar Artery Occlusion) Trial Investigators. Tao C, et al. Among authors: wang j, wang y, wang m, wang c. Circulation. 2022 Jul 5;146(1):6-17. doi: 10.1161/CIRCULATIONAHA.121.058544. Epub 2022 Jun 3. Circulation. 2022. PMID: 35656816
Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial.
Yang H, Xu L, Guan S, Hao X, Ge Z, Tong F, Cao Y, Liu P, Zhou B, Cheng L, Liu M, Liu H, Xie F, Wang S, Peng Y, Wang C, Wang S. Yang H, et al. Among authors: wang s, wang c. BMC Cancer. 2022 Dec 28;22(1):1357. doi: 10.1186/s12885-022-10439-0. BMC Cancer. 2022. PMID: 36577958 Free PMC article. Clinical Trial.
102,168 results
You have reached the last available page of results. Please see the User Guide for more information.